The Utility of Ablative Radiotherapy in Metastatic Breast Cancer
Julia White, MD, from The Ohio State University Comprehensive Cancer Center, discusses the utility of ablative radiotherapy in metastatic breast cancer.
Clinical Pearls
Julia White, MD, professor, director, Breast Radiation Oncology, vice chair, Clinical Research, The Ohio State University Comprehensive Cancer Center, discusses the utility of ablative radiotherapy in metastatic breast cancer.
- An ablative radiotherapy approach to metastatic regions allows for the avoidance of a surgical procedure.
- Though surgical procedures are typically well tolerated, there are inherent risks associated with anesthesia and complications following surgery.
- Patients must stop systemic therapy in order to undergo surgery. With an ablative radiotherapy approach, there are no treatment interruptions.
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More
